Skip to main content
VCbacked
Log inGet Started

Zenas BioPharma

Waltham, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

$100.0M raised
Mar 2026
Post Ipo Equity
BiopharmaHealth CarePharmaceutical

Top Investors

NorwestWellington ManagementPerceptive AdvisorsVivo CapitalNew Enterprise Associates

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Zenas BioPharma

How much funding has Zenas BioPharma raised?
Zenas BioPharma has raised $100.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.
Who are Zenas BioPharma's investors?
Zenas BioPharma's investors include Norwest, Wellington Management, Perceptive Advisors, Vivo Capital, New Enterprise Associates.
Where is Zenas BioPharma headquartered?
Zenas BioPharma is headquartered in Waltham, United States.
What does Zenas BioPharma do?
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
What stage is Zenas BioPharma at?
Zenas BioPharma is at the Post Ipo Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Zenas BioPharma — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/zenas-biopharma. Accessed June 3, 2026.
APA
VCBacked. (2026). Zenas BioPharma — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/zenas-biopharma
Wikipedia (cite web)
{{cite web |title=Zenas BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/zenas-biopharma |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego